Answers are grounded in this paper and cite their sources.
Cardiovascular disease is a leading cause of morbidity and mortality in kidney transplant candidates and recipients. Pre-transplant cardiac tests are frequently used to risk-stratify transplant candidates to optimise medical or interventional therapies in the belief this reduces peri-operative cardiovascular risk, but no studies have definitively determined whether this strategy is clinically or cost effective. A joint British Transplantation Society and British Cardiovascular Society Guideline on cardiovascular assessment of potential adult kidney transplant recipients has recently been written. This manuscript summarises the relevant recommendations from chapters on risk stratification and non-invasive cardiac investigation of adult patients being assessed for kidney transplantation, including the re-evaluation of patients active on the transplant waiting list.
No takes yet. Share an insight, caveat, or question.
Nimmo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: